Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001412741-25-000006·EAGLE PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
EAGLE PHARMACEUTICALS INC
Common Stock · CUSIP: 269796108
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- J. Goldman & Co LP
Shares: 667,108.00 · Class: 5.1%
- J. Goldman Capital Management, Inc.
Shares: 667,108.00 · Class: 5.1%
- GOLDMAN JAY G
Shares: 667,108.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001412741-25-000006
- Form type
- SCHEDULE 13G
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership